173 related articles for article (PubMed ID: 28118755)
21. Mechanism of
Deng JW; Li CY; Huang YP; Liu WF; Zhang Q; Long J; Wu WQ; Huang LH; Zeng GH; Sun XY
J Agric Food Chem; 2024 Mar; 72(12):6372-6388. PubMed ID: 38471112
[TBL] [Abstract][Full Text] [Related]
22. Oxalate transport and calcium oxalate renal stone disease.
Verkoelen CF; Romijn JC
Urol Res; 1996; 24(4):183-91. PubMed ID: 8873376
[TBL] [Abstract][Full Text] [Related]
23. Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium.
Byer K; Khan SR
J Urol; 2005 Feb; 173(2):640-6. PubMed ID: 15643280
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic role of phycocyanin: a study of oxalate mediated renal cell injury.
Farooq SM; Asokan D; Kalaiselvi P; Sakthivel R; Varalakshmi P
Chem Biol Interact; 2004 Aug; 149(1):1-7. PubMed ID: 15294440
[TBL] [Abstract][Full Text] [Related]
25. Heat-shock protein 25 ameliorates calcium oxalate crystal-mediated oxidative stress in renal epithelial cells.
Patel AB; Robertson WG; Choong S; Hothersall JS
BJU Int; 2006 Nov; 98(5):1094-9. PubMed ID: 17034610
[TBL] [Abstract][Full Text] [Related]
26. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
27. Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria.
Grujic D; Salido EC; Shenoy BC; Langman CB; McGrath ME; Patel RJ; Rashid A; Mandapati S; Jung CW; Margolin AL
Am J Nephrol; 2009; 29(2):86-93. PubMed ID: 18698135
[TBL] [Abstract][Full Text] [Related]
28. Cellular adaptive response of distal renal tubular cells to high-oxalate environment highlights surface alpha-enolase as the enhancer of calcium oxalate monohydrate crystal adhesion.
Kanlaya R; Fong-Ngern K; Thongboonkerd V
J Proteomics; 2013 Mar; 80():55-65. PubMed ID: 23352899
[TBL] [Abstract][Full Text] [Related]
29. Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis.
Meimaridou E; Lobos E; Hothersall JS
Am J Physiol Renal Physiol; 2006 Oct; 291(4):F731-40. PubMed ID: 16670437
[TBL] [Abstract][Full Text] [Related]
30. Reactive oxygen species mediated calcium oxalate crystal-induced expression of MCP-1 in HK-2 cells.
Habibzadegah-Tari P; Byer KG; Khan SR
Urol Res; 2006 Feb; 34(1):26-36. PubMed ID: 16397773
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms mediating oxalate-induced alterations in renal cell functions.
Jonassen JA; Cao LC; Honeyman T; Scheid CR
Crit Rev Eukaryot Gene Expr; 2003; 13(1):55-72. PubMed ID: 12839097
[TBL] [Abstract][Full Text] [Related]
32. Chromosomal integration of heterologous oxalate decarboxylase in Lactobacillus plantarum WCFS1 using mobile genetic element Ll.LtrB.
Paul E; Albert A; Ponnusamy S; Venkatesan S; Govindan Sadasivam S
Arch Microbiol; 2019 May; 201(4):467-476. PubMed ID: 30349983
[TBL] [Abstract][Full Text] [Related]
33. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
Abratt VR; Reid SJ
Adv Appl Microbiol; 2010; 72():63-87. PubMed ID: 20602988
[TBL] [Abstract][Full Text] [Related]
34. Cloning and expression of the oxalyl-CoA decarboxylase gene from the bacterium, Oxalobacter formigenes: prospects for gene therapy to control Ca-oxalate kidney stone formation.
Lung HY; Cornelius JG; Peck AB
Am J Kidney Dis; 1991 Apr; 17(4):381-5. PubMed ID: 2008903
[TBL] [Abstract][Full Text] [Related]
35. Adsorption of ethylenediaminetetraacetic dianhydride modified oxalate decarboxylase on calcium oxalate.
Cai XH; Lin RH; Wu J; He JB; Wu YC; Wang XY
Biotech Histochem; 2018; 93(3):220-229. PubMed ID: 29393700
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys.
Yoshioka I; Tsujihata M; Akanae W; Nonomura N; Okuyama A
Urology; 2011 Apr; 77(4):1007.e9-1007.e14. PubMed ID: 21256551
[TBL] [Abstract][Full Text] [Related]
37. Oxalate mediated nephronal impairment and its inhibition by c-phycocyanin: a study on urolithic rats.
Farooq SM; Ebrahim AS; Subramhanya KH; Sakthivel R; Rajesh NG; Varalakshmi P
Mol Cell Biochem; 2006 Mar; 284(1-2):95-101. PubMed ID: 16477383
[TBL] [Abstract][Full Text] [Related]
38. Organic Selenium Alleviated the Formation of Ethylene Glycol-Induced Calcium Oxalate Renal Calculi by Improving Osteopontin Expression and Antioxidant Capability in Dogs.
Liu Y; Xu H; Zhong W; Shen Q; Zhuang T; Huang K
Biol Trace Elem Res; 2015 Dec; 168(2):392-400. PubMed ID: 26018495
[TBL] [Abstract][Full Text] [Related]
39. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
[TBL] [Abstract][Full Text] [Related]
40. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
Khan SR; Thamilselvan S
Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
